WEBSITECHANGES

You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.

Click HERE for details on RSS.

Displaying items 1 to 25 of about 5105

Website Changes

12/01/2020

Concurrent Dexamethasone Limits the Clinical Benefit of Immune Checkpoint Blockade in Glioblastoma

11/30/2020

OncoSynergy Opens Enrollment for Clinical Trial of New Cancer Antibody Therapy, OS2966, in Patients with Recurrent Glioblastoma

11/30/2020

Al Musella`s Thoughts on the SNO 2020 Conference!

11/26/2020

2020 UCLA Brain Tumor Virtual Conference

11/23/2020

New version of NCCN Guidelines for CNS Cancers

11/23/2020

Resection and Surgically Targeted Radiation Therapy for the Treatment of Larger Recurrent or Newly Diagnosed Brain Metastasis: Results From a Prospective Trial

11/22/2020

Brain tumor patients get to interview celebrities!

11/22/2020

INOVIO Presents Clinical Results of its DNA Medicines INO-5401 + INO-9012 in Novel Combination with PD-1 Inhibitor Libtayo® (cemiplimab) in the Treatment of Newly Diagnosed Glioblastoma Multiforme at Society for Neuro-Oncology 2020 Annual Meeting

11/22/2020

CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapy

11/22/2020

DNAtrix Announces Positive Data from Phase 2 CAPTIVE (KEYNOTE-192) Study with DNX-2401 in Patients with Recurrent Glioblastoma Highlighted in an Oral Late-Breaking Presentation During Society for Neuro-oncology (SNO) Annual Meeting

11/20/2020

PLUS THERAPEUTICS ANNOUNCES POSITIVE INTERIM DATA FROM RESPECT™ PHASE 1 CLINICAL TRIAL IN RECURRENT GLIOBLASTOMA

11/19/2020

Novocure Announces 43 Presentations on Tumor Treating Fields at Society for Neuro-Oncology 2020 Virtual Annual Meeting

11/19/2020

NX Development Corp. (NXDC) Launches Gleolan (aminolevulinic acid HCl) Meningioma Phase III Clinical Trial (NXDC-MEN-301)

11/17/2020

PLUS THERAPEUTICS ANNOUNCES WEBINAR TO PRESENT RESPECT™ GLIOBLASTOMA CLINICAL TRIAL UPDATE

11/17/2020

OncoSynergy Opens Enrollment for Clinical Trial of New Cancer Antibody Therapy, OS2966, in Patients with Recurrent Glioblastoma

11/17/2020

xCures launches xACCESS - A new module in their AI-assisted clinical platform

11/15/2020

Clinical Characteristics of High-Grade Glioma with Primary Leptomeningeal Seeding at Initial Diagnosis in a Single Center Study

11/13/2020

GT Medical Technologies Announces First Patient Treated in Registry Trial of GammaTile Therapy for Brain Tumors

11/12/2020

Novocure: A Disruptive Growth Play In Cancer Treatments

11/10/2020

Feasibility of Treating High Grade Gliomas in Children with Tumor-Treating Fields: A Case Series

11/05/2020

Oncoceutics Receives Foundation Grants to Establish an Expanded Access Program for ONC201

11/05/2020

First Patient Treated With Experimental Therapy For Deadly Childhood Brain Cancer

11/04/2020

ANNOUNCING THE LAUNCH OF OUR NEW WEBSITE AND CHANGE OF DOMAIN NAME FROM .Com to .Org

11/04/2020

Problem With News Blast Yesterday

11/03/2020

Clinical efficacy and predictive biomarkers of ONC201 in H3 K27M-mutant diffuse midline glioma